Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00543530 | Pediatric Expanded Access Program-Oral Solution (0831-908) | PHASE3 | COMPLETED | - | — | — | Mar 1, 2001 | Dec 1, 2002 | Nov 30, 2015 | - | — |
| Name | Type | Description |
|---|---|---|
| MK0831 | DRUG | - |
Inclusion Criteria: * Not tolerating current ART regime laboratory status is stable * Able to take oral liquid medications but have difficulty swallowing capsules * Weigh at least 10 kg (22 lbs) Exclusion Criteria: * Has had more than 2 episodes of moderate to severe diarrhea or vomiting lasting ...